Why PacWest Bancorp Shares Are Nosediving Premarket Thursday
PacWest Bancorp. (NASDAQ:PACW) shares are on a freefall in premarket trading amid speculation that the Los Angeles, California-based…
Apple Q2 Earnings: Why Analysts Expect iPhone Maker’s Stock To Hold Up Even If Guidance Falls Flat
Apple, Inc. (NASDAQ:AAPL) is the last among the FAANGs to report its March quarter results. The results are…
Shell’s Strong Operational Performance Continues In Q1, Plans $4B Share BuyBack Program
Shell Plc (NYSE:SHEL) reported Q1 2023 adjusted EBITDA of $21.4 billion, higher than $19.0 billion a year ago, on…
PacWest Bancorp Confirms Strategic Options But Says No Cause For Alarm
Los Angeles, California-based PacWest Bancorp (NASDAQ:PACW) confirmed early Thursday reports about the bank exploring strategic options and assuaged…
Cathie Wood Scoops Up AMD Stock On A Day When It Tanks Over 9%: Also Raises Stake In This Biotech Company
Cathie Wood-led ARK Investment Management bought over 26,200 shares of Advanced Micro Devices, Inc. (NASDAQ:AMD) on Wednesday when…
Tesla, Apple, Western Alliance, ImmunoGen, Qualcomm: Why These 5 Stocks Are Drawing Investors’ Attention Today
U.S. markets ended in the red on Wednesday after recording initial gains following the Federal Reserve hiking the…
Horton’s Hot Streak: Analysts Savor Tim Horton Parent’s Flavorful Q1 Results, Boosting Price Targets
Several analysts are upbeat on the growth prospects of Restaurant Brands International Inc (NYSE:QSR) and raised the price target. Analysts are…
Analyst Skeptical About Viability Of Cash Return Framework In Uncertain Market, Downgrades VNOM
KeyBanc Capital Markets analyst Tim Rezvan downgraded the rating on Viper Energy Partners LP (NASDAQ:VNOM) to Sector Weight from Overweight. The analyst…
Neurocrine Biosciences Clocks 35% Revenue Growth In Q1, Misses On Bottom-Line Performance
Neurocrine Biosciences Inc (NBIX) reported first-quarter FY23 sales of $420.40 million, up 35.4% year over year, beating the consensus of…
Why Diebold Nixdorf Shares Are Tumbling Today
Diebold Nixdorf Inc (NYSE: DBD) shares are down Wednesday as its first-quarter results missed Street expectations. The company also holds ongoing conversations with banking and lending partners to address short- and long-term liquidity needs and capital structure.